TSS
PASG icon

Two Sigma Securities’s Passage Bio PASG Stock Holding History

Two Sigma Securities’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-586
Closed -$4.69K – 1858
2025
Q2 		$4.69K Buy
+586
New +$4.28K ﹤0.01% 1364
2024
Q4 		– Sell
-1,082
Closed -$15.1K – 2787
2024
Q3 		$15.1K Buy
+1,082
New +$17.2K ﹤0.01% 2538
2024
Q1 		– Sell
-2,016
Closed -$40.7K – 3462
2023
Q4 		$40.7K Buy
+2,016
New +$27.8K ﹤0.01% 2633
2023
Q3 		– Sell
-1,030
Closed -$19.4K – 3331
2023
Q2 		$19.4K Buy
+1,030
New +$20.4K ﹤0.01% 2511

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's PASG Position: Q3 2025 in Review

Two Sigma Securities sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 586 shares — an estimated $4.69K sold.

Two Sigma Securities first reported a position in PASG in Q2 2023 and held it in 4 quarters. The position peaked at $40.7K in Q4 2023. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.

  • Two Sigma Securities reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 586 Passage Bio shares in Q3 2025, an estimated $4.69K.
  • Two Sigma Securities first reported a position in Passage Bio in Q2 2023 and held it in 4 quarters.
  • Two Sigma Securities's Passage Bio position peaked at $40.7K in Q4 2023.
  • 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.